Annual Securities Report — FY2025
What AFC-HD AMS Life Science Co.,Ltd. reported for the period from 2025-09-01 to 2026-08-31. Filed by AFC-HD AMS Life Science Co., Ltd.
In the consolidated fiscal year under review, revenue increased, driven by higher revenue and profit in the Pharmaceuticals business and higher revenue in the Healthcare business. However, net income attributable to owners of the parent decreased year on year as a result of recording an impairment loss. The filing also states that the Healthcare business introduced an automatic tablet recovery machine and an automatic PTP packaging machine to reduce labor requirements in production, and includes a share exchange agreement aimed at making Saikaya Department Store Co.,Ltd. a wholly owned subsidiary, with the effective date scheduled for the future.
Komori's summary of this document, not the document's own words.